New Mexico Register / Volume XXXI, Issue 4 / February 25, 2020
This is an amendment
to 16.12.2 NMAC, Section 13 and 15, effective 3/26/2020.
Explanatory paragraph: In 16.12.2.13 NMAC, Subsections A through N were not published as there were no changes. In 16.12.2.15 NMAC, Subsections A through L were not published as there were no changes.
16.12.2.13 ADVANCED PRACTICE REGISTERED NURSE (APRN)
CERTIFIED NURSE PRACTITIONER (CNP):
***
O. Supervision of psychologists in the
prescribing of psychotropic medication by a certified nurse practitioner,
pursuant to Section 61-3-23.5 NMSA 1978 and the Professional Psychologist Act
(Section 61-9-1 et. seq. NMSA 1978).
(1) A
CNP may provide supervision to a
psychologists in the prescribing of psychotropic medication provided the CNP:
(a) holds
a valid, unencumbered NM license as a CNP;
(b) holds
a national certification as a psychiatric-mental health nurse practitioner. An individual who holds a
certification as a CNP conferred by a national nursing certification
organization that is not an approved certification listed above may petition
the board and request approval of the certification. The board shall review the
petition and determine whether the certification and the petitioner’s clinical
practice experience sufficiently substantiate adequate education, didactic and
clinical preparedness, and other factors that establish competency. The
decision of the board is discretionary and shall not be subject to review or
binding on any future petition.
(c) has
a minimum of two years of experience prescribing as a psychiatric-mental health
nurse practitioner
(d) is
not currently participating in any board of nursing’s alternative to discipline
program, diversion program;
(e) is
able to meet all requirements to serve as an independently licensed prescribing
clinician as laid out in the Professional
Psychologist Act (Section 61-9 NMSA 1978) and 16.22 NMAC; and
(f) performing
the supervision is within the scope of practice of the CNP.
(2) Reporting
obligations to the New Mexico board of nursing by a CNP providing supervision
to a psychologist in the prescribing of psychotropic medication:
(a) within
15 days of entering into the supervising relationship with each psychologist
being supervised. The notification shall
consist of:
(i) the name and
license number of the psychologist
(ii) the date of
entry into the supervising relationship
(iii) the anticipated
end of the supervising relationship
(b) within
15 days of severing the supervisory relationship with a psychologist. The notification shall consist of:
(i) the
name and license number of the psychologist
(ii) the
date of the end of the supervising
relationship
(3) A
CNP who provides supervision to a psychologist in the prescribing of
psychotropic medication must follow the Professional Psychologist Act (Section 61-9
NMSA 1978) and rules promulgated by the New Mexico board of psychologist examiners.
[16.12.2.13 NMAC - Rp, 16.12.2.13 NMAC, 10/1/2016; A, 9/12/2017; A, 5/3/2018; A, 3/26/2020]
16.12.2.15 ADVANCED PRACTICE REGISTERED NURSE (APRN) CLINICAL NURSE SPECIALIST (CNS):
***
M. Supervision of psychologists in the prescribing of
psychotropic medication by a clinical nurse specialist, pursuant to Section
61-3-23.5 NMSA 1978 and the Professional Psychologist Act (Section 61-9-1 et.
seq. NMSA 1978).
(1) A CNS may provide
supervision to a psychologists in the prescribing of psychotropic medication
provided the CNS:
(a) holds
a valid, unencumbered NM license as a CNS;
(b) holds
a national certification as a psychiatric-mental health clinical nurse
specialist. An individual who holds a certification
as a CNS conferred by a national nursing certification organization that is not
an approved certification listed above may petition the board and request
approval of the certification. The board shall review the petition and determine
whether the certification and the petitioner’s clinical practice experience
sufficiently substantiate adequate education, didactic and clinical
preparedness, and other factors that establish competency. The decision of the
board is discretionary and shall not be subject to review or binding on any
future petition.
(c) has
a minimum of two years of experience prescribing as a psychiatric-mental health
clinical nurse specialist
(d) is not currently participating in any
board of nursing’s alternative to discipline program, diversion program;
(e) is
able to meet all requirements to serve as an independently licensed prescribing
clinician as laid out in the
Professional Psychologist Act (Section 61-9 NMSA 1978) and 16.22 NMAC; and
(f) performing
the supervision is within the scope of practice of the CNS.
(2) Reporting obligations to the New
Mexico board of nursing by a CNS providing supervision to a psychologist in the
prescribing of psychotropic medication:
(a) within
15 days of entering into the supervising relationship with each psychologist
being supervised. The notification shall
consist of:
(i) the
name and license number of the psychologist
(ii) the
date of entry into the supervising relationship
(iii) the
anticipated end of the supervising relationship
(b) within
15 days of severing the supervisory relationship with a psychologist. The notification shall consist of:
(i) the
name and license number of the psychologist
(ii) the
date of the end of the supervising relationship
(3) A
CNS who provides supervision to a psychologist in the prescribing of
psychotropic medication must follow the Professional Psychologist Act (Section
61-9 NMSA 1978) and rules promulgated by the New Mexico board of psychologist
examiners.
[M.] N. Advanced practice committee.
(1) The board may appoint a minimum of a six member advisory committee to assist the board in regulating the advanced practice of nursing.
(2) The committee shall assist and advise the board in the review of issues related to the advanced practice of nursing.
(3) The committee shall be composed of representatives from each advanced practice area regulated by the board.
[16.12.2.15 NMAC - Rp, 16.12.2.15 NMAC, 10/1/2016; A, 5/3/2018; A, 3/26/2020]